Asia-Pacific Prebiotics for Infant Formula Market – Industry Trends and Forecast to 2027

  • Food & Beverage
  • Published Report
  • Dec 2019
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 179
  • No of Figures: 25

Asia-Pacific Prebiotics for Infant Formula Market By Type (Human Milk Oligosaccharides (HMOS), Galactooligosaccharides (GOS), Fructooligosaccharides (FOS), Mannan-Oligosaccharides (MOS), Polydextrose (PDX), Lactulose (LOS), Inulin), Source (Bacteria, Algae, Fungi, Plants & Vegetables), Grade (Inorganic, Organic), Form (Powder, Liquid), Product Type (Standard Formula, Toddler Formula, Follow Up Formula, Special Formula), Infant Age (0-6 Months, 6-12 Months, 1-3 Years), Country (Japan, China, South Korea, India, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, New Zealand, Vietnam and rest of Asia-Pacific)

Market Analysis and Insights: Asia-Pacific Prebiotics for Infant Formula Market

Prebiotics for infant formula market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market research analyses that the market is growing with the CAGR of 7.1% in the forecast period of 2020 to 2027 and expected to reach USD 574.29 million by 2027. Increasing infant population and spending capacity of customers in the developing countries will accelerate the market in forecast period.

Prebiotics are the rich source of nutrition which is given to infants for their healthy growth. The various prebiotics like human milk oligosaccharides, galactooligosaccharides (GOS), fructooligosaccharides (FOS), mannan-oligosaccharides (MOS) and others improves the digestive system as well as immune system in the infants. In addition, the new research reports stating new benefits like memory enhancement in infant that has already been set to get introduced in the market at higher levels. The automation in production, transportation and storing facility is supposed to make supply much faster and precise.

The new launches require extensive research and development activities owing to utilization of prebiotics in infant formulas augmented to market growth in Asian countries. For instance, In January, 2019, Nestlé announced the investment for new R&D center in china for infant and mother nutrition product development as China holds the stronger market share for infant nutrition. According to JD & COFCO the infant formula market is China for year 2018 accounted around USD 29,600 million which created stiff competition between global and domestic players. Growth in the research and development activities and the engagement of the company’s for the development of the new product, leading their business expansion in Asian Countries.

This prebiotics for infant formula market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Asia-Pacific Prebiotics for Infant formula Market Scope and Market Size

Prebiotics for infant formula market is segmented on the basis type, source, grade, form, product type and infant age. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the market is segmented into human milk oligosaccharides (HMOS), galactooligosaccharides (GOS), fructooligosaccharides (FOS), mannan-oligosaccharides (MOS), polydextrose (PDX), lactulose (LOS), and inulin. Human milk oligosaccharides (HMOS) are dominating the prebiotics for infant formula market, as it acts as substitute for mother milk. The rising number of preterm and premature babies in Asia-pacific region is accelerating the consumption of prebiotics based infant formulas. For instance in February, 2018, according to the WHO preterm birth article India and China holds the two countries account the higher number of count in preterm babies. The India holds the count of 3,519,100 preterm followed by China with 1,172,300 preterm, such rising number pf preterm infant is driving the market growth by creating huge demand for infant nutrition.
  • On the basis of source, the market is segmented into bacteria, algae, fungi, plants & vegetables and others. Plants & vegetables are dominating the market as they have major advantage of taste over others sources used for prebiotics. In addition, prebiotics sourced from the plants and vegetables are marketed as the vegetarian nutrition, which provides advantage for the market. For instance, in 2016, according to the vegan society launch of vegetarian products in Southeast Asia is increased by almost 140% while comparing it to the year 2012. Such acceptance and demand from the people is driving the growth this particular segment.
  • On the basis of grade, the market is segmented into inorganic and organic. Inorganic prebiotics for infant formula is dominating the market due to less prices and wide offering comparing to the organic prebiotics infant formula. Organic foods are extra priced while comparing to the inorganic products and as the Asia region major base or population has mid-level or low economy the inorganic infant formulas are more preferred. For instance, in December, 2018, according to the JD only organic food share in the infant market food market was only around 3.78 percent. Such clear dominance and strong hold of inorganic food in the Asian region is helping the segment to dominate the market.
  • On the basis of form, the market is segmented into powder and liquid.  Powder is dominating the market as the major base of customers in Asia-Pacific region prefers the products which has last storage period. Major base of customer has less preference towards daily consumption of prebiotics for their infants which also supplement the sale of powder products rather than liquid.
  • On the basis of product type, the market is segmented into standard formula, special formula, follow up formula and toddler formula. The standard formula dominating the market as there is huge demand for the infant formulas in Chinese market with affordable price. The supporting structure and initiative to increase the production of infant formulas is helping the segment as standard formula is suitable for the all infant age groups and mainly for infant having 0-12 months. For instance in June 2019, China country’s central planner and several ministries have introduced document aiming to achieve the production of baby formula around 60 percent by domestic players.  
  • On the basis of infant age, the market is segmented into 0-6 months, 6-12 months and 1-3 years. The 6-12 months segment is dominating the Asia-Pacific prebiotics for infant formula market as at this age parents majorly prefers prebiotics based formulas as a complementary food for their children. Asia-pacific region holds major customer’s base having low income especially in countries like China, India and others where rate of malnutrition is higher. Such rate of malnutrition can be reduced by prebiotic based infant nutrition which is helping this segment to dominate as the organisation like WHO, UNICEF, and others are strongly promoting it. Such as according to the WHO almost 2 out of 5 children’s are belonging to the family having low income.

Prebiotics for Infant Formula Market Country Level Analysis

Asia-Pacific prebiotics for infant formula market is analysed and market size information is provided by country, by type, source, grade, form, product type and infant age as referenced above.

The countries covered in the prebiotics for infant formula market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific.

Japan dominates the Asia-Pacific prebiotics for infant formula market due to growing R&D expenditure and strong establishment of new competitors in Asian countries, while the China is expected to grow with the highest growth rate in the forecast period of 2020 to 2027 because of increased adaptation of prebiotics for infant formula by the food and beverage and pharmaceutical industries. In September, 2019, Japan Government lifted the ban which they had implied on the liquid infant formula which showed a rising demand in the market.

Prebiotics for Infant Formula Market, By Product Type

Asia-Pacific Prebiotics for Infant Formula Market

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Strong Research Activities and Clinical Trials to Formulate New Prebiotics Solution 

Prebiotics for infant formula market also provides you with detailed market analysis for every country growth in prebiotics for infant formula industry with prebiotics for infant formula sales, components sales, impact of technological development prebiotics for infant formula and changes in regulatory scenarios with their support for the prebiotics for infant formula market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Prebiotics for Infant Formula Market Share Analysis

Prebiotics for infant formula market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, concept cars, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Asia-Pacific prebiotics for infant formula market.

The major players covered in the report are Jennewein Biotechnologie GmbH, zuChem Inc., Biosynth Carbosynth, ELICITYL SA, Dextra Laboratories Limited, Glycom A/S, Tereos, Ingredion Incorporated, Royal FrieslandCampina N.V., Südzucker AG, Cargill, Incorporated., Fonterra Co-operative Group, Royal Cosun, COSUCRA, New Francisco (Yunfu City) Biotechnology Corporation Limited, Dana Dairy Group, Glycosyn LLC, DUPONT and other domestic players in Asia-Pacific. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

For instance,

  • In November 2019, NZMP, a nutrition brand of the Fonterra Co-operative Group conducted the reseller’s conference namely South & East Asia resellers conference 2019 under which they showcased their offering for the Asian customers. Through the seminars and sharing new marketing strategy with resellers to improve product sale company increased their relation as well as distribution channel for customers.
  • In September 2019, Domo, Kievit, DMV and Nutrifeed, the ingredient brands of the Royal FrieslandCampina N.V. showcased their products for the Asian consumers. The event is conducted at Fi Asia Bangkok in which company showcased their product range for ingredients offering and dairy products. Through this company is demonstrated their offering for customer in Asia-Pacific market as well as strengthened their presence also.

Expansion, product showcase and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for prebiotics for infant formula through expanded model range.

Customization Available : Asia-Pacific Prebiotics for Infant Formula Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), product under development data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 2 ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 3 ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 4 ASIA-PACIFIC FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 5 ASIA-PACIFIC FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 6 ASIA-PACIFIC FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 7 ASIA-PACIFIC GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 8 ASIA-PACIFIC GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 9 ASIA-PACIFIC INULIN IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 10 ASIA-PACIFIC POLYDEXTROSE (PDX) IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 11 ASIA-PACIFIC MANNAN-OLIGOSACCHARIDES (MOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 12 ASIA-PACIFIC LACTULOSE (LOS) IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 13 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 14 ASIA-PACIFIC PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 15 ASIA-PACIFIC PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 16 ASIA-PACIFIC BACTERIA IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 17 ASIA-PACIFIC FUNGI IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 18 ASIA-PACIFIC ALGAE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 19 ASIA-PACIFIC OTHERS IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 20 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 21 ASIA-PACIFIC INORGANIC IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 22 ASIA-PACIFIC ORGANIC IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 23 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 24 ASIA-PACIFIC POWDER IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 25 ASIA-PACIFIC LIQUID IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 26 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 27 ASIA-PACIFIC STANDARD FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 28 ASIA-PACIFIC SPECIAL FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 29 ASIA-PACIFIC FOLLOW UP FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 30 ASIA-PACIFIC TODDLER FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 31 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 32 ASIA-PACIFIC 6-12 MONTHS IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 33 ASIA-PACIFIC 0-6 MONTHS IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 34 ASIA-PACIFIC 1-3 YEARS IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 35 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET, BY COUNTRY,  2018-2027 (USD MILLION)

TABLE 36 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 37 ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 38 ASIA-PACIFIC FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 39 ASIA-PACIFIC GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 40 ASIA-PACIFIC FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 41 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 42 ASIA-PACIFIC PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 43 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 44 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 45 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET,  BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 46 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 47 JAPAN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 48 JAPAN HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 49 JAPAN FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 50 JAPAN GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 51 JAPAN FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 52 JAPAN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 53 JAPAN PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 54 JAPAN PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 55 JAPAN PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 56 JAPAN PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 57 JAPAN PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 58 CHINA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 59 CHINA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 60 CHINA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 61 CHINA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 62 CHINA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 63 CHINA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 64 CHINA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 65 CHINA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 66 CHINA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 67 CHINA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 68 CHINA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 69 SOUTH KOREA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 70 SOUTH KOREA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 71 SOUTH KOREA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 72 SOUTH KOREA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 73 SOUTH KOREA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 74 SOUTH KOREA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 75 SOUTH KOREA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 76 SOUTH KOREA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 77 SOUTH KOREA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 78 SOUTH KOREA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 79 SOUTH KOREA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 80 INDIA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 81 INDIA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 82 INDIA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 83 INDIA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 84 INDIA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 85 INDIA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 86 INDIA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 87 INDIA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 88 INDIA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 89 INDIA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 90 INDIA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 91 AUSTRALIA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 92 AUSTRALIA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 93 AUSTRALIA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 94 AUSTRALIA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 95 AUSTRALIA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 96 AUSTRALIA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 97 AUSTRALIA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 98 AUSTRALIA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 99 AUSTRALIA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 100 AUSTRALIA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 101 AUSTRALIA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 102 SINGAPORE PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 103 SINGAPORE HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 104 SINGAPORE FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 105 SINGAPORE GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 106 SINGAPORE FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 107 SINGAPORE PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 108 SINGAPORE PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 109 SINGAPORE PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 110 SINGAPORE PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 111 SINGAPORE PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 112 SINGAPORE PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 113 MALAYSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 114 MALAYSIA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 115 MALAYSIA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 116 MALAYSIA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 117 MALAYSIA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 118 MALAYSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 119 MALAYSIA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 120 MALAYSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 121 MALAYSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 122 MALAYSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 123 MALAYSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 124 THAILAND PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 125 THAILAND HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 126 THAILAND FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 127 THAILAND GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 128 THAILAND FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 129 THAILAND PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 130 THAILAND PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 131 THAILAND PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 132 THAILAND PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 133 THAILAND PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 134 THAILAND PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 135 INDONESIA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 136 INDONESIA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 137 INDONESIA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 138 INDONESIA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 139 INDONESIA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 140 INDONESIA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 141 INDONESIA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 142 INDONESIA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 143 INDONESIA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 144 INDONESIA PREBIOTICS FOR INFANT FORMULA MARKET,  BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 145 INDONESIA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 146 PHILIPPINES PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 147 PHILIPPINES HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 148 PHILIPPINES FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 149 PHILIPPINES GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 150 PHILIPPINES FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 151 PHILIPPINES PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 152 PHILIPPINES PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 153 PHILIPPINES PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 154 PHILIPPINES PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 155 PHILIPPINES PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 156 PHILIPPINES PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 157 NEW ZEALAND PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 158 NEW ZEALAND HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 159 NEW ZEALAND FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 160 NEW ZEALAND GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 161 NEW ZEALAND FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 162 NEW ZEALAND PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 163 NEW ZEALAND PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 164 NEW ZEALAND PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 165 NEW ZEALAND PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 166 NEW ZEALAND PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 167 NEW ZEALAND PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 168 VIETNAM PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 169 VIETNAM HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 170 VIETNAM FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 171 VIETNAM GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 172 VIETNAM FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 173 VIETNAM PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 174 VIETNAM PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 175 VIETNAM PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 176 VIETNAM PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 177 VIETNAM PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 178 VIETNAM PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 179 REST OF ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19